- INTRODUCTION TO THE SCHIZOPHRENIA SPECTRUM
- HISTORY OF PSYCHOSIS: FROM KRAEPELIN TO MODERN DSM/ICD
- CONCEPTUAL MODELS OF SCHIZOPHRENIA: NEURODEVELOPMENTAL VS. NEURODEGENERATIVE
- CULTURAL AND HISTORICAL PERSPECTIVES ON PSYCHOTIC ILLNESS
- NOSOLOGY AND CLASSIFICATION OF PSYCHOTIC DISORDERS
- EARLY THEORIES OF MADNESS AND CONTEMPORARY RELEVANCE
- PHENOMENOLOGY OF HALLUCINATIONS AND DELUSIONS
- CROSS-CULTURAL EXPRESSIONS OF PSYCHOSIS
- RECOVERY MOVEMENTS AND DEINSTITUTIONALIZATION
- STIGMA AND SOCIAL CONSTRUCTION OF SCHIZOPHRENIA
- GENETICS OF SCHIZOPHRENIA AND RELATED DISORDERS
- EPIGENETIC MECHANISMS IN PSYCHOSIS
- DOPAMINE HYPOTHESIS AND BEYOND
- GLUTAMATE AND NMDA RECEPTOR HYPOFUNCTION
- GABAERGIC DYSFUNCTION IN SCHIZOPHRENIA
- NEUROINFLAMMATION AND IMMUNE PATHWAYS
- OXIDATIVE STRESS AND MITOCHONDRIAL ABNORMALITIES
- STRUCTURAL BRAIN CHANGES: MRI AND DTI FINDINGS
- FUNCTIONAL BRAIN NETWORKS IN PSYCHOSIS
- NEURODEVELOPMENTAL RISK FACTORS AND CRITICAL PERIODS
- THE CLINICAL HIGH-RISK (CHR) STATE FOR PSYCHOSIS
- EARLY WARNING SIGNS AND SCREENING STRATEGIES
- GENETIC COUNSELING FOR AT-RISK FAMILIES
- PREVENTION AND EARLY INTERVENTION MODELS
- ROLE OF STRESS AND TRAUMA IN ONSET OF PSYCHOSIS
- ADOLESCENT BRAIN DEVELOPMENT AND PSYCHOSIS RISK
- YOUTH AND YOUNG ADULT PSYCHOSIS: PUBLIC HEALTH APPROACHES
- EARLY COGNITIVE DECLINE AND NEUROCOGNITIVE MARKERS
- BIOMARKERS FOR PSYCHOSIS PREDICTION
- ETHICAL CHALLENGES IN PRE-EMPTIVE DIAGNOSIS
- POSITIVE SYMPTOMS: HALLUCINATIONS AND DELUSIONS
- NEGATIVE SYMPTOMS: APATHY, ANHEDONIA, ALOGIA
- COGNITIVE IMPAIRMENTS IN SCHIZOPHRENIA
- THOUGHT DISORDER AND DISORGANIZED SPEECH
- INSIGHT AND ANOSOGNOSIA
- PSYCHOMOTOR ABNORMALITIES AND CATATONIA
- EMOTIONAL PROCESSING AND SOCIAL COGNITION
- THEORY OF MIND DEFICITS IN PSYCHOSIS
- NEUROPSYCHOLOGY OF WORKING MEMORY IN SCHIZOPHRENIA
- LANGUAGE AND SEMANTIC PROCESSING IN THOUGHT DISORDER
- SCHIZOPHRENIA: CORE DIAGNOSTIC CRITERIA AND SUBTYPES
- SCHIZOAFFECTIVE DISORDER: INTERSECTION OF MOOD AND PSYCHOSIS
- BRIEF PSYCHOTIC DISORDER: ACUTE ONSET AND RESOLUTION
- DELUSIONAL DISORDER: THEMES AND MECHANISMS
- SHARED PSYCHOTIC DISORDER (FOLIE À DEUX)
- SUBSTANCE/MEDICATION-INDUCED PSYCHOSIS (CONCEPTUAL LECTURES ONLY)
- PSYCHOSIS DUE TO MEDICAL CONDITIONS (CONCEPTUAL PATHOPHYSIOLOGY)
- CATATONIA: PATHOPHYSIOLOGY AND SYNDROMIC VARIANTS
- POSTPARTUM PSYCHOSIS
- LATE-ONSET SCHIZOPHRENIA AND VERY-LATE-ONSET SCHIZOPHRENIA-LIKE PSYCHOSIS
- GLOBAL INCIDENCE AND PREVALENCE OF PSYCHOTIC DISORDERS
- URBANICITY AND MIGRATION AS RISK FACTORS
- PRENATAL AND PERINATAL ADVERSITIES
- CHILDHOOD ADVERSITY AND PSYCHOSIS
- CANNABIS AND OTHER SUBSTANCE USE AS RISK FACTORS
- SOCIOECONOMIC DETERMINANTS OF PSYCHOSIS
- GENE–ENVIRONMENT INTERACTIONS IN SCHIZOPHRENIA
- GENDER DIFFERENCES IN INCIDENCE AND COURSE
- ETHNORACIAL DISPARITIES AND DIAGNOSTIC BIAS
- CLIMATE, SEASON OF BIRTH, AND SCHIZOPHRENIA
- PHARMACOLOGY OF FIRST-GENERATION ANTIPSYCHOTICS
- PHARMACOLOGY OF SECOND-GENERATION ANTIPSYCHOTICS
- MECHANISMS OF CLOZAPINE AND TREATMENT-RESISTANT SCHIZOPHRENIA
- LONG-ACTING INJECTABLE ANTIPSYCHOTICS: CONCEPTS AND EVIDENCE
- PHARMACOGENOMICS IN ANTIPSYCHOTIC SELECTION
- SIDE EFFECT PROFILES AND MECHANISMS (E.G., METABOLIC, EXTRAPYRAMIDAL)
- DOPAMINE SUPERSENSITIVITY AND TARDIVE DYSKINESIA PATHWAYS
- NOVEL TARGETS: TAAR1, MUSCARINIC, AND GLUTAMATERGIC APPROACHES
- NEUROSTIMULATION AND BRAIN CIRCUIT MODULATION (ECT, TMS THEORY)
- PSYCHEDELIC AND CANNABINOID-BASED RESEARCH IN PSYCHOSIS
- COGNITIVE BEHAVIORAL THEORY FOR PSYCHOSIS (CBTP CONCEPTS)
- FAMILY PSYCHOEDUCATION AND EXPRESSED EMOTION
- SOCIAL SKILLS TRAINING PRINCIPLES
- SUPPORTED EMPLOYMENT AND EDUCATION MODELS
- RECOVERY-ORIENTED CARE AND PERSON-CENTERED PLANNING
- COGNITIVE REMEDIATION AND NEUROPLASTICITY
- PEER SUPPORT MODELS AND EVIDENCE
- PSYCHODYNAMIC PERSPECTIVES ON PSYCHOSIS
- TRAUMA-INFORMED CARE PRINCIPLES
- COMMUNITY INTEGRATION AND HOUSING MODELS
- DUAL DIAGNOSIS: SUBSTANCE USE AND PSYCHOSIS
- DEPRESSION AND SUICIDE RISK IN SCHIZOPHRENIA
- ANXIETY DISORDERS IN SCHIZOPHRENIA
- PHYSICAL HEALTH IN PSYCHOTIC DISORDERS (CARDIOVASCULAR, METABOLIC)
- INTELLECTUAL DISABILITY AND PSYCHOSIS
- PSYCHOSIS IN NEURODEGENERATIVE DISEASE (PARKINSON’S, ALZHEIMER’S)
- PSYCHOSIS IN EPILEPSY
- GENDER AND REPRODUCTIVE HEALTH CONSIDERATIONS
- CULTURAL VARIANTS AND INDIGENOUS PERSPECTIVES
- FORENSIC AND LEGAL ASPECTS OF PSYCHOTIC DISORDERS
- BIG DATA AND MACHINE LEARNING IN PSYCHOSIS PREDICTION
- CONNECTOMICS AND BRAIN NETWORK MODELING
- IMMUNE MODULATION AND PSYCHOSIS
- NEUROENDOCRINE PATHWAYS (HPA AXIS, CORTISOL)
- GUT–BRAIN AXIS AND MICROBIOME RESEARCH IN PSYCHOSIS
- DIGITAL PHENOTYPING AND MOBILE SENSING FOR RELAPSE PREDICTION
- GENOMIC EDITING AND ETHICAL CONSIDERATIONS
- GLOBAL MENTAL HEALTH AND PSYCHOSIS POLICY
- REDUCING STIGMA THROUGH EDUCATION AND MEDIA
- BUILDING INTEGRATED CARE SYSTEMS FOR SEVERE MENTAL ILLNESS